Delivering your ambition | Deals Spring 2020

Jun 11, 2020 / News

Recent testimonials

Alastair Smith, CEO, Avacta Group:

“It has, at times, been a challenging journey on AIM and finnCap has always been supportive, providing sensible and commercial advice. We are delighted with the increasing interest in our two therapeutic technology platforms and the application of Affimers to develop novel diagnostic assays, most recently a COVID-19 antigen test. finnCap delivered a very successful fundraise, generating substantial demand over and above the £48m raised.  It was an outstanding result and the advice to bring the funding forward when market conditions softened was key in delivering a successful result. This substantial fundraising allows us to re-capitalise the business and provides us with the resources to unlock the potential value in the therapeutic and diagnostic pipelines.”

David Payne, Chairman, Castleton Technology:

“I am very grateful for your help on the transaction with MRI. Under the most difficult conditions you managed us through the process with calm good sense and great attention to our shareholders best interests. I know we made a very good choice in having finnCap as our advisors, not just on this transaction, but throughout our journey.”